Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors

In today’s global plan to completely eradicate hepatitis C virus (HCV), the essential list of medications used for HCV treatment are direct-acting antivirals (DAAs), as interferon-sparing regimens have become the standard-of-care (SOC) treatment. HCV nonstructural protein 5A (NS5A) inhibitors are a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamdy, Jehad, Emadeldin, Nouran, Hamed, Mostafa M., Frakolaki, Efseveia, Katsamakas, Sotirios, Vassilaki, Niki, Zoidis, Grigoris, Hirsch, Anna K. H., Abdel-Halim, Mohammad, Abadi, Ashraf H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146377/
https://www.ncbi.nlm.nih.gov/pubmed/35631457
http://dx.doi.org/10.3390/ph15050632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146377/
https://www.ncbi.nlm.nih.gov/pubmed/35631457
http://dx.doi.org/10.3390/ph15050632

Ejemplares similares